Comparative Genomics and Proteomics in Drug Discovery: Vol 58
Editat de John Parrington, Kevin Cowarden Limba Engleză Hardback – 9 noi 2006
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 368.14 lei 6-8 săpt. | |
CRC Press – 5 sep 2019 | 368.14 lei 6-8 săpt. | |
Hardback (1) | 1008.47 lei 6-8 săpt. | |
CRC Press – 9 noi 2006 | 1008.47 lei 6-8 săpt. |
Preț: 1008.47 lei
Preț vechi: 1366.29 lei
-26% Nou
Puncte Express: 1513
Preț estimativ în valută:
193.01€ • 203.61$ • 160.84£
193.01€ • 203.61$ • 160.84£
Carte tipărită la comandă
Livrare economică 02-16 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780415396530
ISBN-10: 0415396530
Pagini: 164
Ilustrații: 27 b/w images and 27 line drawings
Dimensiuni: 156 x 234 x 17 mm
Greutate: 0.43 kg
Ediția:1
Editura: CRC Press
Colecția Taylor & Francis
ISBN-10: 0415396530
Pagini: 164
Ilustrații: 27 b/w images and 27 line drawings
Dimensiuni: 156 x 234 x 17 mm
Greutate: 0.43 kg
Ediția:1
Editura: CRC Press
Colecția Taylor & Francis
Public țintă
Professional Practice & DevelopmentCuprins
1. Comparative Genomics and Drug Discovery in Trypanosomatids 2. The Practical Implications of Comparative Kinetoplastid Genomics 3. The Relevance of Host Genes in Malaria 4. Nicotinic Acetylcholine Receptors as Drug/Chemical Targets, Contributions from Comparative Genomics, Forward and Reverse Genetics 5. Discovery of Novel Sodium Channel Inhibitors - A Gene Family-Based Approach 6. 'Omics' in Translational Medicine : Are They Lost in Translation? 7. Drug-Target Discovery In Silico : Using the Web to Identify Novel Molecular Targets for Drug Action
Notă biografică
John Parrington and Kevin Coward, Department of Pharmacology, University of Oxford, UK.
Descriere
Comparative Genomics and Proteomics in Drug Discovery gives an overview of how emerging genomic and proteomic technologies are making significant contributions to global drug discovery programs. Each chapter is written by respected authorities, with hands-on experience, from both academic and pharmaceutical backgrounds.